LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    Newsroom

    Topic

    Document type

    • 26/05/2020

      Joint statement on the EU Climate Law
    • 20/05/2020

      The impact of COVID-19 on patients with chronic or life-threatening conditions
    • 20/05/2020

      EuropaBio position on Germline Genome Editing
    • 20/05/2020

      EuropaBio highlights synergies between biotechnology and Farm to Fork and Biodiversity Strategy ambitions
    • 30/04/2020

      How soon can we respond to COVID-19?
    • 30/04/2020

      EuropaBio reply letter to European Patients’ Forum’s call on COVID-19
    • 30/04/2020

      CRISPR and Coronavirus
    • 30/04/2020

      Clinical Trials and Coronavirus
    • 30/04/2020

      World Haemophilia Day – Interview with Amanda Bok (EHC)
    • 29/04/2020

      European Bioeconomy Alliance (EUBA) Position on the EU Green Deal
    • 28/04/2020

      Primary Immunodeficiencies Week – Interview Johan Prevot (IPOPI)
    • 17/04/2020

      World Haemophilia Day – Interview with Dr. Ian Winburn (Pfizer)
    • 17/04/2020

      World Haemophilia Day – A Message from Paul Perrault (CSL Behring)
    • 17/04/2020

      World Haemophilia Week – Interview with Philip Wood (Sobi)
    • 10/04/2020

      European Industry trade and supply chain needs to respond to Covid-19 – Joint Letter to the EU Trade Ministers
    • 30/03/2020

      Biotechnology spearheads the fight against COVID-19
    Prev page
    1...2425262728...30
    Next page

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.